Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

BI-10773 improves glycemic control in large study in type 2 diabetes

Sep. 27, 2010

Fixed-dose fenofibrate/pravastatin plus ezetimibe reduces hyperlipidemia in type 2 diabetes

Sep. 23, 2010

Data reported from extension study of Qnexa in obesity

Sep. 22, 2010

Takeda identifies new GPR119 receptor agonists

Sep. 22, 2010

Pronova Biopharma and Abbott amend agreement for Omacor

Sep. 22, 2010

Ablynx reports follow-up data from phase I study of ALX-0141

Sep. 21, 2010

Vantia identifies new vasopressin V1A receptor antagonists

Sep. 21, 2010

Trial of TT-223/GLP-1 analogue combination in type 2 diabetes does not meet endpoints

Sep. 21, 2010

Oramed Pharma reports data from exploratory study of oral insulin capsule

Sep. 20, 2010

BioCryst Pharmaceuticals' BCX-4208 shows efficacy in gout

Sep. 20, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...